Overview
Set the purpose, scope, audience, and boundaries before the detailed chapters.
Free Downloadable Template
EU MDR Annex II and III technical file for a medical device, from device description to post-market surveillance. Download the editable blank, or create a draft from your recordings in Docsie.
Use this file to assemble controlled device evidence in the definition order of Annex II followed by Annex III. Enter document references and evidence status; an empty record is an evidence gap, not a conformity conclusion. Regulatory applicability and release decisions belong to the authorized reviewers.
Complete bracketed fields with approved information. Duplicate modules and rows as needed; record the reason for any section marked not applicable.
Document [ID and revision] Owner [Role] Scope [Organization, site or product]
Effective date [Date] Approval [Controlled record] Next review [Date or trigger]
| Device identity | Controlled description |
|---|---|
| Name intended purpose and users | [Exact labelling wording and source revision] |
| Patients indications and contraindications | [Population and approved claims] |
| Operating principle and novel features | [Description and supporting evidence] |
| Classification and Basic UDI DI | [Class, rule, reviewed rationale and identifier] |
| Previous or similar generations | [Comparison and supporting controlled reference] |
| Variant or accessory | Configuration materials and specification | Evidence |
|---|---|---|
| [Identifier] | [Values, units and compatibility] | [Drawing, specification and revision] |
| Supplied information | Controlled version and scope | Consistency review |
|---|---|---|
| [Label, IFU or implant card] | [Language, variant and document ID] | [Purpose, claims and revision check] |
| [Warning or residual-risk disclosure] | [Exact wording, signal word and location] | [Linked risk and review result] |
| [Promotional claim] | [Exact claim and channel] | [Evidence and labelling consistency] |
| Stage or process | Site supplier and controls | Controlled evidence |
|---|---|---|
| [Design stage] | [Design output and review gate] | [Record and revision] |
| [Manufacturing step] | [Site, subcontractor, parameters and control] | [Validation or verification reference] |
Keep one record per requirement and retain the reviewer justification for applicability. Split large matrices by chapter. | Requirement and applicability | Method and cited specification | Evidence and review status | |---|---|---| | [GSPR ID; applicable or justified not applicable] | [Conformity method; standard or common specification and edition] | [Evidence ID, section, version and reviewer finding] | | [GSPR ID] | [Method and exact reference] | [Evidence or open gap] |
| Risk management element | Controlled record and conclusion status |
|---|---|
| Plan scope and acceptability criteria | [Lifecycle phases, method and approved criteria] |
| Hazard hazardous situation and harm | [Risk ID, sequence of events and evidence] |
| Initial estimation | [Severity/probability method and source rating] |
| Control and verification | [Inherent design, protective measure or information; implementation and effectiveness evidence] |
| Residual risk and disclosure | [Recorded evaluation, disclosure and labelling reference] |
| Overall benefit risk evaluation | [Authorized conclusion and evidence; unresolved gaps] |
| Production feedback | [Inputs, review trigger and risk-file update] |
| Risk and control ID | Implementation evidence | Effectiveness evidence and status |
|---|---|---|
| [IDs] | [Design or process record] | [Test, criterion, result and reviewed conclusion] |
Repeat by test area such as software, biocompatibility, packaging, performance or sterilization when applicable. | Test area and requirement | Method configuration and criterion | Result and conclusion | |---|---|---| | [Test ID, risk and requirement] | [Standard edition, device configuration, samples and exact acceptance criterion] | [Report, values, units, deviation and recorded conclusion] | | [Not performed] | [Reviewed rationale and existing data relied on] | [Evidence limitations and decision] |
| Evaluation element | Controlled evidence |
|---|---|
| Plan and claims | [Intended purpose, benefits, outcome parameters and plan revision] |
| Data sources | [Investigations, literature or equivalence evidence and comparison] |
| Appraisal and analysis | [Methods, populations, endpoints, statistics and limitations] |
| Conclusions and gaps | [Recorded safety/performance/benefit-risk conclusion and unresolved evidence] |
| PMCF and clinical follow up | [Plan, activities, results and evaluation report references] |
| Public clinical summary | [Where applicable: controlled summary and consistency review] |
| Claim or GSPR | Clinical or test evidence | Risk or labelling consistency |
|---|---|---|
| [Identifier] | [Report and section] | [Linked record and reviewer result] |
| Surveillance element | Plan or report record |
|---|---|
| Device scope and objectives | [Devices, period and PMS plan reference] |
| Data sources | [Complaints, vigilance, service, literature, registries, feedback or PMCF] |
| Indicators and trend method | [Definition, threshold, unit, rationale and review frequency] |
| Incident handling and communication | [Classification rules, decision authority and applicable reviewed obligations] |
| Feedback to other files | [Risk, clinical evaluation and corrective-action links] |
| PMS report or PSUR | [Applicable report type, period, version, findings and authorized conclusion] |
| Surveillance finding | Assessment and linked action | Review evidence |
|---|---|---|
| [Source and signal] | [Risk or clinical impact; CAPA or update] | [Decision, owner and record] |
| Term or abbreviation | Approved meaning | Defining source |
|---|---|---|
| [Term used in the file] | [Expansion or definition] | [Controlled source] |
8 Repeatable Chapter Patterns
Teams preparing a technical documentation file (eu mdr) from existing source material. Repeat a procedure, checklist, or reference chapter where needed, and keep only the sections your source material supports.
Set the purpose, scope, audience, and boundaries before the detailed chapters.
Keep exact settings, field values, commands, and supporting references easy to look up.
Place the relevant hazards, precautions, and source warnings before the actions they affect.
Connect identified risks to their assessment, controls, review, and retained evidence.
Connect requirements and intended use to the checks, methods, results, and evidence addressing them.
Organize the evaluation scope, supporting clinical evidence, analysis, and documented conclusions.
Organize post-market information sources, monitoring, review, findings, and follow-up actions.
Define the terms and abbreviations used throughout the document.
Use this file to assemble controlled device evidence in the definition order of Annex II followed by Annex III. Enter document references and evidence status; an empty record is an evidence gap, not a conformity conclusion. Regulatory applicability and release decisions belong to the authorized reviewers.
Complete bracketed fields with approved information. Duplicate modules and rows as needed; record the reason for any section marked not applicable.
Document [ID and revision] Owner [Role] Scope [Organization, site or product]
Effective date [Date] Approval [Controlled record] Next review [Date or trigger]
| Device identity | Controlled description |
|---|---|
| Name intended purpose and users | [Exact labelling wording and source revision] |
| Patients indications and contraindications | [Population and approved claims] |
| Operating principle and novel features | [Description and supporting evidence] |
| Classification and Basic UDI DI | [Class, rule, reviewed rationale and identifier] |
| Previous or similar generations | [Comparison and supporting controlled reference] |
| Variant or accessory | Configuration materials and specification | Evidence |
|---|---|---|
| [Identifier] | [Values, units and compatibility] | [Drawing, specification and revision] |
| Supplied information | Controlled version and scope | Consistency review |
|---|---|---|
| [Label, IFU or implant card] | [Language, variant and document ID] | [Purpose, claims and revision check] |
| [Warning or residual-risk disclosure] | [Exact wording, signal word and location] | [Linked risk and review result] |
| [Promotional claim] | [Exact claim and channel] | [Evidence and labelling consistency] |
| Stage or process | Site supplier and controls | Controlled evidence |
|---|---|---|
| [Design stage] | [Design output and review gate] | [Record and revision] |
| [Manufacturing step] | [Site, subcontractor, parameters and control] | [Validation or verification reference] |
Keep one record per requirement and retain the reviewer justification for applicability. Split large matrices by chapter. | Requirement and applicability | Method and cited specification | Evidence and review status | |---|---|---| | [GSPR ID; applicable or justified not applicable] | [Conformity method; standard or common specification and edition] | [Evidence ID, section, version and reviewer finding] | | [GSPR ID] | [Method and exact reference] | [Evidence or open gap] |
| Risk management element | Controlled record and conclusion status |
|---|---|
| Plan scope and acceptability criteria | [Lifecycle phases, method and approved criteria] |
| Hazard hazardous situation and harm | [Risk ID, sequence of events and evidence] |
| Initial estimation | [Severity/probability method and source rating] |
| Control and verification | [Inherent design, protective measure or information; implementation and effectiveness evidence] |
| Residual risk and disclosure | [Recorded evaluation, disclosure and labelling reference] |
| Overall benefit risk evaluation | [Authorized conclusion and evidence; unresolved gaps] |
| Production feedback | [Inputs, review trigger and risk-file update] |
| Risk and control ID | Implementation evidence | Effectiveness evidence and status |
|---|---|---|
| [IDs] | [Design or process record] | [Test, criterion, result and reviewed conclusion] |
Repeat by test area such as software, biocompatibility, packaging, performance or sterilization when applicable. | Test area and requirement | Method configuration and criterion | Result and conclusion | |---|---|---| | [Test ID, risk and requirement] | [Standard edition, device configuration, samples and exact acceptance criterion] | [Report, values, units, deviation and recorded conclusion] | | [Not performed] | [Reviewed rationale and existing data relied on] | [Evidence limitations and decision] |
| Evaluation element | Controlled evidence |
|---|---|
| Plan and claims | [Intended purpose, benefits, outcome parameters and plan revision] |
| Data sources | [Investigations, literature or equivalence evidence and comparison] |
| Appraisal and analysis | [Methods, populations, endpoints, statistics and limitations] |
| Conclusions and gaps | [Recorded safety/performance/benefit-risk conclusion and unresolved evidence] |
| PMCF and clinical follow up | [Plan, activities, results and evaluation report references] |
| Public clinical summary | [Where applicable: controlled summary and consistency review] |
| Claim or GSPR | Clinical or test evidence | Risk or labelling consistency |
|---|---|---|
| [Identifier] | [Report and section] | [Linked record and reviewer result] |
| Surveillance element | Plan or report record |
|---|---|
| Device scope and objectives | [Devices, period and PMS plan reference] |
| Data sources | [Complaints, vigilance, service, literature, registries, feedback or PMCF] |
| Indicators and trend method | [Definition, threshold, unit, rationale and review frequency] |
| Incident handling and communication | [Classification rules, decision authority and applicable reviewed obligations] |
| Feedback to other files | [Risk, clinical evaluation and corrective-action links] |
| PMS report or PSUR | [Applicable report type, period, version, findings and authorized conclusion] |
| Surveillance finding | Assessment and linked action | Review evidence |
|---|---|---|
| [Source and signal] | [Risk or clinical impact; CAPA or update] | [Decision, owner and record] |
| Term or abbreviation | Approved meaning | Defining source |
|---|---|---|
| [Term used in the file] | [Expansion or definition] | [Controlled source] |
Bring your recordings and select this template. Docsie organizes supported material into chapters and task articles for your team to review.
Downloads are editable blank templates. Review generated content against your source material before use.
Compliance program manual built on the elements of an effective program: governance, risk, policies, reporting, review.
House rules for voice, grammar, formatting, UI and code text, and terminology that keep documentation consistent.
Top-level security policy plus topic-specific policies grouped by control theme, aligned to ISO/IEC 27002.